한글목차

2025년에는 107억 2,000만 달러, 2032년에는 308억 8,000만 달러에 이를 것으로 예상되며, 2025년부터 2032년까지 연평균 성장률(CAGR) 16.3%로 성장할 전망입니다.

그림. 표적 약물전달 시장 점유율(%), 2025년 지역별

표적 약물전달은 제약 화합물을 신체의 표적 작용 부위에 직접 전달함으로써 치료 효과를 극대화하고 부작용을 최소화하는 것을 의미합니다. 특정 세포 표면 수용체와 항원을 인식하는 타겟팅 리간드와 부위와 약물의 캡슐화 및 접합이 포함됩니다. 이를 통해 약물 캐리어 시스템은 신체의 질병 세포와 조직을 선택적으로 표적화할 수 있어 작용 부위에서 약물의 생체이용률을 높여 전신적인 부작용을 줄일 수 있습니다. 표적 약물전달은 약물의 부위 특이적인 작용을 가능하게 하기 때문에 암, 심혈관 질환, 신경 질환 등 다양한 만성 질환의 효과적인 관리에 큰 가능성을 가지고 있습니다.

시장 역학 :

표적 약물전달 시장은 주로 만성 질환의 세계 유병률 증가, 뛰어난 효능 및 안전성 프로파일을 갖춘 정밀 의약품에 대한 수요 증가, 첨단 약물 약물 전달 기술에 대한 제약 기업의 R&D 투자 증가로 인한 것입니다. 또한, 만성 질환을 앓고 있는 노인 인구 증가, 나노메딘 및 표적 요법에 대한 진행 중인 조사, 신규 표적 약물 제제의 규제 승인 등은 시장 기업에게 유리한 기회를 창출하는 주요 요인입니다. 그러나 표적 전달 시스템과 관련된 개발 비용의 높이, 신흥 국가의 임상 연구를위한 적절한 인프라의 부족, 표적 약물 제제의 복잡성은 급속한 보급을 억제하는 주요 과제입니다. 합리적인 가격으로 안정적인 표적 전달 솔루션을 개발하기 위한 업계 전문가와 연구자의 다양한 노력이 앞으로 몇 년동안 이러한 제약을 극복하는 데 도움이 될 것입니다.

본 조사의 주요 특징

• 본 보고서에서는 세계의 표적 약물전달 시장을 상세하게 분석하여 2024년을 기준연도으로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 복합 성장률(CAGR%)을 제공합니다.
• 또한 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명합니다.
• 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 상시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
• 세계의 표적 약물전달 시장에서 주요 기업 프로파일을 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 실적, 전략 등의 매개변수를 기반으로 제공합니다.
• 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 상시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
• 세계의 약물전달 시장은 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 지원합니다.
• 이해관계자는 세계의 표적 약물전달 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.

목차

제1장 조사의 목적과 전제조건

• 조사 목적
• 전제조건
• 약어

제2장 시장 전망

• 보고서 설명
  • 시장 정의와 범위
• 주요 요약
• Coherent Opportunity Map(COM)

제3장 시장 역학, 규제, 동향 분석

• 시장 역학
  • 성장 촉진요인
  • 억제요인
  • 기회
• 영향 분석
• 시장 동향
• 주요 발전
• 규제 시나리오
• 제조업체 수익
• 인수와 제휴 시나리오
• 제품 출시, 승인
• 자금 조달 및 투자
• PEST 분석
• Porter's Five Forces 분석

제4장 세계의 표적 약물전달 시장- 코로나 바이러스(COVID-19) 팬데믹의 영향

• 전체적인 영향
• 정부의 대처
• COVID-19에 의한 시장에 대한 영향

제5장 세계의 표적 약물전달 시장, 질환 유형별, 2020년-2032년(10억 달러)

• 심혈관 질환
• 폐질환
• 감염증
• 내분비 질환
• 종양성 질환

제6장 세계의 표적 약물전달 시장, 용도별, 2020년-2032년,(10억 달러)

• 1차 표적
• 2차 표적
• 3차 표적

제7장 세계의 표적 약물전달 시장, 최종 사용자별, 2020년-2032년,(10억 달러)

• 병원
• 클리닉
• 기타

제8장 세계의 표적 약물전달 시장, 지역별, 2020년-2032년,(10억 달러)

• 북미
• 라틴아메리카
• 유럽
• 아시아태평양
• 중동
• 아프리카

제9장 경쟁 구도

• 기업 프로파일
  • AbbVie Inc.
  • Sanofi
  • Arrowhead Pharmaceuticals, Inc.
  • Baxter International Inc.
  • AstraZeneca
  • Boston Scientific Corporation
  • Depomed, Inc.
  • Fraunhofer Gesellschaft Munchen
  • Janssen Global Services, LLC
  • Luye Pharma Group
  • Pfizer Inc.
  • Quark Pharmaceuticals Inc.
  • Rexahn Pharmaceuticals Inc.
  • Savara Inc.
  • Roche Holding AG
  • Suda Limited
  • Taiwan Liposome Company, Ltd.
  • Vectura Group PLC

제10장 분석가 추천

• 기회
• 애널리스트의 견해
• Coherent Opportunity Map

제11장 참고문헌과 조사방법

• 참고문헌
• 조사 방법

영문목차

Global Targeted Drug Delivery Market is estimated to be valued at USD 10.72 Bn in 2025 and is expected to reach USD 30.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 16.3% from 2025 to 2032.

Figure. Targeted Drug Delivery Market Share (%), By Region 2025

Targeted drug delivery refers to the delivery of pharmaceutical compounds directly to the targeted sites of action in the body, thus maximizing the therapeutic effects and minimizing the side effects. It involves the encapsulation or conjugation of drugs with targeting ligands or moieties that recognize specific cell-surface receptors or antigens. This allows the drug carrier system to selectively target the diseased cells or tissues in the body, thereby increasing the bioavailability of drugs at the site of action and reducing systemic side effects. Targeted drug delivery holds tremendous potential for the effective management of various chronic diseases like cancer, cardiovascular ailments, neurological disorders, etc. as it allows site-specific action of drugs.

Market Dynamics:

The targeted drug delivery market is primarily driven by the rising prevalence of chronic diseases globally, boosting the demand for precision medicines with superior efficacy and safety profiles, increasing R&D investments by pharmaceutical companies in advanced drug delivery technologies. Furthermore, the growing geriatric population susceptible to chronic health conditions, ongoing research on nanomedicines and targeted therapies, and regulatory approvals of novel targeted drug formulations are some key factors creating lucrative opportunities for market players. However, high development costs associated with targeted delivery systems, lack of proper infrastructure for clinical research in emerging nations, and complexity of targeted drug formulations are major challenges restraining the rapid adoption. Various initiatives by industry experts and researchers to develop affordable and stable targeted delivery solutions can help overcome these limitations in the coming years.

Key Features of the Study:

• This report provides an in-depth analysis of the global targeted drug delivery market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global targeted drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this includes AbbVie Inc., Sanofi , Arrowhead Pharmaceuticals, Inc., Baxter International Inc., AstraZeneca , Boston Scientific Corporation, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC, Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Taiwan Liposome Company, Ltd., and Vectura Group PLC.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• Global targeted drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global targeted drug delivery market.

Detailed Segmentation-

• By Disease Type:
  • Cardiovascular Diseases
  • Pulmonary Diseases
  • Infectious Diseases
  • Endocrine Diseases
  • Oncological Disorders
• By Application:
  • First Order Targeting
  • Second Order Targeting
  • Third Order Targeting
• By End User:
  • Hospitals
  • Clinics
  • Others
• By Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East
  • Africa
• Company Profiles:
  • AbbVie Inc.
  • Sanofi
  • Arrowhead Pharmaceuticals, Inc.
  • Baxter International Inc.
  • AstraZeneca
  • Boston Scientific Corporation
  • Depomed, Inc.
  • Fraunhofer Gesellschaft Munchen
  • Janssen Global Services, LLC
  • Luye Pharma Group
  • Pfizer Inc.
  • Quark Pharmaceuticals Inc.
  • Rexahn Pharmaceuticals Inc.
  • Savara Inc.
  • Roche Holding AG
  • Suda Limited
  • Taiwan Liposome Company, Ltd.
  • Vectura Group PLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Disease Type
  • Market Snapshot, By Application
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Key Developments
• Regulatory Scenario
• Manufacturer Revenue
• Acquisitions and Partnerships Scenario
• Product Launches/Approvals
• Funding and Investments
• PEST Analysis
• Porter's Analysis

4. Global Targeted Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Government Initiatives
• COVID-19 Impact on the Market

5. Global Targeted Drug Delivery Market, By Disease Type, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Cardiovascular Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Pulmonary Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Infectious Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Endocrine Diseases
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Oncological Disorders
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Targeted Drug Delivery Market, By Application, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• First Order Targeting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Second Order Targeting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Third Order Targeting
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Targeted Drug Delivery Market, By End User, 2020 - 2032, (USD Bn)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Targeted Drug Delivery Market, By Region, 2020 - 2032, (USD Bn)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Region, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
    • GCC
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
  • Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
    • North Africa
    • Central Africa
    • South Africa

9. Competitive Landscape

• Company Profiles
  • AbbVie Inc.*
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Sanofi
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Arrowhead Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Baxter International Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • AstraZeneca
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Boston Scientific Corporation
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Depomed, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Fraunhofer Gesellschaft Munchen
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Janssen Global Services, LLC
    • Company Highlights
    • Product Portfolio
    • Key Highlights
    • Financial Performance
    • Market Strategies
  • Luye Pharma Group
  • Pfizer Inc.
  • Quark Pharmaceuticals Inc.
  • Rexahn Pharmaceuticals Inc.
  • Savara Inc.
  • Roche Holding AG
  • Suda Limited
  • Taiwan Liposome Company, Ltd.
  • Vectura Group PLC

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact